The FDA has approved a years-in-development treatment for multidrug-resistant HIV, a boon for those who've become resistant to most or all available HIV meds.
Researchers from New York’s Aaron Diamond AIDS Research Center presented a new long-lasting PrEP pill at the 25th Conference on Retroviruses and Opportunistic Infections (CROI).
UCLA has developed an intervention program called LINK LA that connects ex-inmates to continuous healthcare once they are out of jail and helps them maintain their viral suppression in the outside world.